CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 6,035 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 8
  • Pediatric or adult subjects with diagnosis of any tumor, malignancy, pre-malignant disorder, or suspected premalignant familial syndromes
  • Biological relatives of patients with tumor, malignancy, pre-malignant disorder, or suspected familial pre-malignant syndrome
  • Healthy volunteers without history of malignancy and no family member currently being treated for cancer
  • Biospecimens collected with minimal additional risk during routine patient care procedures
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01109394
NCT01109394N/ARecruitingOn Track
Long Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

National Cancer Institute (NCI)·observational·Posted Apr 23, 2010·Updated Jun 24, 2026

In Brief

An observational study for Sarcoma and 4 related conditions. Currently recruiting, targeting 6,035 participants across 5 sites.

Detailed Summary

Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood, serum, tissue, urine, or tumors of children who have cancer or adults who have common childhood cancers. To develop this repository, additional samples will be collected from children and adults who have been diagnosed with common childhood cancers such as leukemia and tumors of the central nervous system. Objectives: \- To collect and store blood, serum, tissue, urine, or tumor samples of children who have cancer or adults who have common childhood cancers. Eligibility: * Individuals who have been diagnosed with a common childhood cancer (e.g., leukemia) regardless of patient age. * Children, adolescents, and adults who have been diagnosed with a type of cancer more commonly found in adults. Design: * Extra blood, serum (the liquid part of blood), tissue, urine, or tumor samples will be collected from participants at a time when sampling is required for medical care or as part of a research study. * No additional procedures will be performed for the sole purpose of obtaining additional tumor tissue, aside from what is required for clinical care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ARecruiting
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 23, 2010
Enrollment StartApr 21, 2010
TodayJul 2, 2026
Posted 16.2 years ago

Arms & Interventions

1/Cohort 1other

Adult or Pediatric subjects, with any malignancy, pre-malignancy, suspected malignancy, family history of malignancy, or without malignancy undergoing surgery or well visit.

2/Cohort 2other

Human samples, specimens and data collected on IRB approved protocols that are now closed

3/Cohort 3other

Parent/caregiver of a participating pediatric or adult subject who is being treated for, or who has previously been treated for any form of pediatric cancer.